{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:08:22Z","timestamp":1761581302070,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.urolonc.2015.02.016","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T20:22:48Z","timestamp":1429561368000},"page":"265.e15-265.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical outcomes in a contemporary series of \u201cyoung\u201d patients with castration-resistant prostate cancer who were 60 years and younger"],"prefix":"10.1016","volume":"33","author":[{"given":"Orazio","family":"Caffo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodoro","family":"Sava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sveva","family":"Macrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Spizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Aieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Lodde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Alesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"D\u05f3Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Ratta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Fratino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Lo Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fable","family":"Zustovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Ruatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"La Russa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore Luca","family":"Burgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Maines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Veccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Galligioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2015.02.016_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2015.02.016_bib2","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2015.02.016_bib3","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/jnci\/djp278","article-title":"Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005","volume":"101","author":"Welch","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2015.02.016_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1464-410x.2001.02141.x","article-title":"Does age influence the behaviour of localized prostate cancer?","volume":"87","author":"Parker","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2015.02.016_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-5347(06)00566-0","article-title":"Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies","volume":"176","author":"Halabi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7150\/jca.4192","article-title":"Impact of age at diagnosis on outcomes in men with Castrate-Resistant Prostate Cancer (CRPC)","volume":"4","author":"Humphreys","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.urolonc.2015.02.016_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.12389","article-title":"Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy","volume":"21","author":"Kimura","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.02.016_bib9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa041318","article-title":"Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer","volume":"351","author":"Petrylak","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.02.016_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"de Bono","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2015.02.016_bib11","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.02.016_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.02.016_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.02.016_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.02.016_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1213755","article-title":"Alpha emitter radium-223 and survival in metastatic prostate cancer","volume":"369","author":"Parker","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.02.016_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrurol.2014.91","article-title":"Prostate cancer in young men: an important clinical entity","volume":"11","author":"Salinas","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0022-5347(17)61510-6","article-title":"Adenocarcinoma of the prostate in men less than 56 years old: a study of 65 cases","volume":"105","author":"Silber","year":"1971","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-5347(17)63840-0","article-title":"Clinical adenocarcinoma of the prostate in patients under 50 years of age","volume":"93","author":"Tjaden","year":"1965","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jso.2930040305","article-title":"Prostatic adenocarcinoma occurring in men under 50 years of age","volume":"4","author":"Johnson","year":"1972","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0090-4295(03)00404-7","article-title":"Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003","volume":"62","author":"Khan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.02.016_bib21","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)66929-7","article-title":"Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database","volume":"164","author":"Smith","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.urology.2003.10.045","article-title":"Do younger men have better biochemical outcomes after radical prostatectomy?","volume":"63","author":"Freedland","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.02.016_bib23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ijrobp.2009.06.052","article-title":"Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer","volume":"77","author":"Burri","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2015.02.016_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urology.2010.12.046","article-title":"Prostate cancer in men less than the age of 50: a comparison of race and outcomes","volume":"78","author":"Parker","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.02.016_bib25","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/cncr.24324","article-title":"Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study","volume":"115","author":"Lin","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2015.02.016_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.4525","article-title":"Survival benefit from first docetaxel treatment for cabazitaxel plus prednisone compared with mitoxantrone plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in the TROPIC trial","volume":"29","author":"Sartor","year":"2011","journal-title":"J Clin Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.urolonc.2015.02.016_bib27","article-title":"Exploratory analysis of survival benefit and prior docetaxel (D) treatment in COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC)","volume":"30","author":"Chi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2014.06.027","article-title":"TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer","author":"Steurer","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.02.016_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/pcan.2013.4","article-title":"Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer","volume":"16","author":"Schaefer","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2015.02.016_bib30","article-title":"Defining young in the context of prostate cancer","author":"Chambers","year":"2014","journal-title":"Am J Mens Health"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:33Z","timestamp":1761041073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1078143915001088"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.02.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes in a contemporary series of \u201cyoung\u201d patients with castration-resistant prostate cancer who were 60 years and younger","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}